Back to Search
Start Over
Identification of anaplastic lymphoma kinase fusion in clear cell renal carcinoma (ALK-tRCC): a precision oncology medicine case report.
- Source :
-
Recenti progressi in medicina [Recenti Prog Med] 2021 Jan; Vol. 112 (1), pp. 14e-15e. - Publication Year :
- 2021
-
Abstract
- Background: Translocation-associated renal cell carcinoma involving ALK (ALK-tRCC) is a rare subtype of adult renal cell carcinoma (RCC) reported in recent years.<br />Case Presentation: A new Italian case of ALK-tRCC was reported. The patient was a female 44-year-old with a metastatic and pretreated RCC. The tumor showed a rearrangement of ALK gene in tumor cells detected by targeted next-generation sequencing panel. The patient received oral alectinib therapy and achieved a partial response.<br />Conclusions: ALK-tRCC is a rare subtype of adult RCC. Its diagnosis is very difficult because the genomic alteration spectrum is very wide. We suggested that metastatic RCCs should be screened for uncommon genomic alterations expecially in good performance status pretreated resistant/refractory patients.
- Subjects :
- Adult
Anaplastic Lymphoma Kinase genetics
Female
High-Throughput Nucleotide Sequencing
Humans
Precision Medicine
Carcinoma, Renal Cell diagnosis
Carcinoma, Renal Cell drug therapy
Carcinoma, Renal Cell genetics
Kidney Neoplasms diagnosis
Kidney Neoplasms drug therapy
Kidney Neoplasms genetics
Subjects
Details
- Language :
- English
- ISSN :
- 2038-1840
- Volume :
- 112
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Recenti progressi in medicina
- Publication Type :
- Academic Journal
- Accession number :
- 33512368
- Full Text :
- https://doi.org/10.1701/3525.35133